DoH and MIT- Koch Institute Partner to Advance AI-Driven Cancer Research
ABU DHABI, UAE, July 3, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and the MIT – Koch Institute for Integrative Cancer Research have announced a strategic collaboration to advance AI-enabled oncology research, translational science and bioconvergence innovation. Leveraging...
Evangel Hospital Launches “3 Instruments of Peace” Service in Support of Advance Medical Directives Implementation
HONG KONG, July 3, 2026 /PRNewswire/ -- The Advance Medical Directives (AMD) legislation will come into effect on 31 July 2026, allowing adults with mental capacity to express their preferences in advance regarding end-of-life care and life-sustaining treatments. Evangel Hospital welcomes this development. Dr. Chui Siu Hang, Hospital Superintendent cum Chief Medical Executive, stated that in light of...
Home Control Upgrades Singapore Headquarters: Deepens Regional Strategic Footprint and Strengthens Healthcare Ecosystem Collaboration
HONG KONG, July 3, 2026 /PRNewswire/ -- Home Control International Limited ("Home Control" or the "Company", together with its subsidiaries, the "Group"; Stock Code: 1747.HK) is pleased to announce that its Singapore headquarters and core operations team officially relocated in May 2026 to a new office at 6 Shenton Way, #27-10, OUE Downtown 2, situatied in the heart of...
Sky Labs Showcases ‘CART BP pro’ for Potential Use in Drug Clinical Trials on Global Stage
BASEL, Switzerland and SEOUL, South Korea, July 3, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 2nd that it introduced its data platform business at the 9th Digital Biomarkers in Clinical Trials Summit in Basel, Switzerland, highlighting the potential of its ring-type cuffless blood pressure monitor, 'CART...
Malaysia Faces Rising Childhood Myopia Challenge: VISTA Eye Specialist, EssilorLuxottica, UiTM and SK Jalan U3 Join Forces to Protect Children’s Vision
School-based initiative identifies vision problems in 1 in 2 students screened, while providing specialist eye screening, prescription spectacles and preventive healthcare directly to students and families SHAH ALAM, Malaysia, July 3, 2026 /PRNewswire/ -- Childhood myopia (short-sightedness) is becoming one of the fastest-growing public health challenges worldwide. Research by the Brien Holden Vision Institute estimates that nearly half of...
Shanghai SinoUnited Hospital Announced Availability of World’s First CAR-T Therapy for Solid Tumors in Advanced Gastric Cancer
SHANGHAI, July 3, 2026 /PRNewswire/ -- Shanghai SinoUnited Hospital today announced the availability of satricabtagene autoleucel ("satri-cel"), the world's first chimeric antigen receptor (CAR) T-cell therapy approved for the treatment of solid tumors, for eligible patients with Claudin18.2-positive, HER2-negative advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma who have failed at least two prior lines of therapy. This milestone marks...
Nona Biosciences Appoints Dr. Peng Wang as Chief Operating Officer to Advance Platform Capabilities and Drive Operational Excellence
CAMBRIDGE, Mass., July 3, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Peng Wang as Chief Operating Officer (COO). Dr. Wang will be based in Suzhou and report directly to Dr. Di Hong,...
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
TAIPEI, July 3, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced its participation in the BIO International Convention (BIO 2026), held in San Diego, California, from June 22 to June 25, 2026. Having participated in the BIO...
Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
End-of-treatment data from ENRICH demonstrated higher HBsAg loss rates, consistent with ENSURE Cohort 4, confirming the role of BRII-179 in priming immune responses for functional cure strategies End-of-treatment data from ENHANCE did not demonstrate improved HBsAg loss rates compared to ENSURE Cohorts 2 and 3, informing selection of combination regimen going forward As previously disclosed, advancement of...
Neurophet Supplies ‘Neurophet AQUA’ to Raffles Medical in Singapore
Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Securing meaningful clinical reference SEOUL, South Korea, July 2, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has...
